Unknown

Dataset Information

0

Effect of green tea catechins on the pharmacokinetics of digoxin in humans.


ABSTRACT: Background:Previous in vitro studies have reported the inhibitory effect of green tea on p-glycoprotein (p-gp) encoded by ABCB1. This study aimed to investigate the effect of green tea on the pharmacokinetics of digoxin, a typical probe drug of p-gp. Methods:Sixteen healthy volunteers participated in this study. At Day 1, 0.5 mg of digoxin was administered via oral route. After a 14-day washout period, 630 mg of green tea catechins (GTC) was administered via oral route, followed by 0.5 mg of digoxin 1 hour later. From Day 16 through Day 28, 630 mg of GTC was administered alone. At Day 29, 630 mg of GTC and 0.5 mg of digoxin were administered in the same way as Day 15. Blood samples for the pharmacokinetic assessments of digoxin were collected up to 8 hours after each dose. Pharmacokinetic parameters were estimated by noncompartmental analysis. Area under the curve (AUC) and peak plasma concentration (Cmax) were compared using mixed effect model between digoxin alone and digoxin with GTC. ABCB1 was genotyped to determine whether its polymorphism affects digoxin-GTC interaction. Results:Fifteen subjects completed the study. Compared to digoxin alone, the concomitant administration of digoxin and GTC significantly reduced the systemic exposure of digoxin: geometric mean ratios (GMR) and 90% confidence intervals (CI) of area under the concentration-time curve from time 0 to the last measurable time (AUClast) and Cmax were 0.69 (0.62-0.75) and 0.72 (0.61-0.85), respectively. The concomitant administration of digoxin and GTC following pretreatment of GTC (Day 29) similarly reduced the AUClast (GMR [90% CI]: 0.67 [0.61-0.74]) and Cmax (GMR [90% CI]: 0.74 [0.63-0.87]). In the comparison of the percentage changes from Day 1 (digoxin single administration) of AUClast between genotypes, C1236T variant type showed a significant difference to wild-type on Day 15 (concomitant administration of digoxin and GTC) (P=0.005). Conclusion:This study demonstrates that the coadministration of GTC reduces the systemic exposure of digoxin regardless of pretreatment of GTC.

SUBMITTER: Kim TE 

PROVIDER: S-EPMC6044363 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of green tea catechins on the pharmacokinetics of digoxin in humans.

Kim Tae-Eun TE   Shin Kwang-Hee KH   Park Jeong-Eun JE   Kim Min-Gul MG   Yun Yeo-Min YM   Choi Dong-Hee DH   Kwon Kyoung Ja KJ   Lee Jongmin J  

Drug design, development and therapy 20180710


<h4>Background</h4>Previous in vitro studies have reported the inhibitory effect of green tea on p-glycoprotein (p-gp) encoded by <i>ABCB1</i>. This study aimed to investigate the effect of green tea on the pharmacokinetics of digoxin, a typical probe drug of p-gp.<h4>Methods</h4>Sixteen healthy volunteers participated in this study. At Day 1, 0.5 mg of digoxin was administered via oral route. After a 14-day washout period, 630 mg of green tea catechins (GTC) was administered via oral route, fol  ...[more]

Similar Datasets

| S-EPMC7084675 | biostudies-literature
| S-EPMC2998685 | biostudies-literature
| S-EPMC4596745 | biostudies-literature
| S-EPMC8272076 | biostudies-literature
| S-EPMC6470784 | biostudies-literature
| S-EPMC2762814 | biostudies-literature
| S-EPMC2408886 | biostudies-other
| S-EPMC3188397 | biostudies-literature
| S-EPMC5340117 | biostudies-literature
| S-EPMC4548173 | biostudies-literature